7
Total investments
3
Early stage
1
Mid stage
2
Late stage
4y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board & Investor
Jan 2025
Your new teammate in the lab! Our lab platform takes over tedious and error-prone manual tasks in 3D cell culture, aiming to replace animal studies. A standardised repository of protocols lets you set up new experiments within minutes. Our AI-based quality control provides real-time transparency on the state of your cell culture, allowing you to worry less and make well-informed decisions.
Investor
Jan 2024
Lindis Blood Care is a medical technology company aiming to set the new gold standard in oncological blood management by combining currently used filter technologies with its trifunctional antibody to reliably remove EpCAM-positive cancer cells from intraoperative blood with its medical device CATUVAB®.
CATUVAB® has the potential of making autologous blood transfusion possible during oncological surgeries, by ensuring that no tumor cells with metastasizing potential will be given back to the patient. Thereby making autologous blood transplant accessible to cancer patients while eliminating the negative side effects associated with allogenic blood transfusions.
Seed Investor
Dec 2023
👉Our vision: Bringing the search experience known from the web into each company. amberSearch offers a multimedial enterprise search that makes the knowledge contained within pictures, videos, text or audio files available to every employee to work based on that knowledge rather than recreating knowledge.
👉The problem: Have you ever spend too much time looking for that all important piece of information within your company? A third of us spend between 5-25 minutes searching every time (!) we want to find the right information within our company.
👉Our solution: An intelligent and multimedia enterprise search engine to help employees to quickly and fully capture all relevant information and documents within their organisation.
👉Want to find out more? Check out our website or read our success stories:
🔎 Müller Maschinentechnik: https://ambersearch.medium.com/m%C3%BCller-maschinentechnik-zentralisiert-zugang-zu-know-how-f%C3%BCr-mitarbeiter-erfolgreich-ff7a108da4bb
🔎 RAG: https://ambersearch.medium.com/wie-expertenwissen-im-unternehmen-demokratisiert-werden-kann-am-beispiel-der-rag-2863cab99980
🔎 Blog amberSearch: https://ambersearch.medium.com/
Board Chair & Investor
Aug 2023
RESPILIQ™ - “the liquid breath”
Premature babies in the incubator, patients with acute lung failure in the intensive care unit or COPD patients at home: they all suffer from the same potentially fatal condition: hypercapnia = an increased level of CO2 in the blood.
In Germany alone there are around 400,000 people a year!
Hypercapnia is one of the major challenges in the therapy of acute lung failure and long-term weaning in ICU and in the outpatient treatment of chronic obstructive pulmonary disease (COPD), which has not yet been adequately solved.
Our goal is to revolutionize therapy and significantly improve survival and, above all, the quality of life of these large patient groups suffering from hypercapnia.
Instead of tackling the problem through the lungs, RESPILIQ™ uses the human gut as a respiratory organ. The human intestine forms a highly effective exchange membrane for carbon dioxid (CO2). In the gut, RESPILIQ™ can bind CO2 from the intestinal fluid and excrete it via naturalis. Administered orally or rectally, RESPILIQ™ initiates a life-saving reduction of pCO2 in the blood.
O11 biomedical GmbH is a spin-off from the Institute for Applied Medical Engineering, Dept. of Biohybrids & Medical Textiles (BioTex) at RWTH Aachen University | Aachen University Hospital. Our team consists of highly dedicated biologists, physicians and engineers.
The product development center is located on the Brightlands Chemelot Campus in close cooperation with the Aachen Maastricht Institute for Biobased Materials (AMIBM).
Investor Pre-Seed
Jan 2023
Was ist Leadnow?
Wir sind ein junges, dynamisches Start-up aus Stuttgart, dessen Ziel es ist, das Influencer-Marketing auf ein völlig neues Level zu heben. Mit unserer Plattform connecten wir Influencer mit den passenden Unternehmenskunden und ermöglichen so, den authentischsten Markenauftritt für beide Seiten zu gewährleisten.
Du bist Influencer?
Als Influencer profitierst du bei uns einerseits von den zahlreichen Kooperationsangeboten und andererseits von einer unkomplizierten Vertragsabwicklung, ohne die dir bekannten bürokratischen Hindernisse. Damit du dich vollkommen auf dein Business fokussieren kannst, übernehmen wir für dich die Rechnungsausstellung, sowie das nachträgliche Reporting. Zudem kannst du dir gefiltert nur die Kooperationen anzeigen lassen, die für dich persönlich finanziell attraktiv sind.
Du hast ein Unternehmen?
Als Unternehmen findest du bei uns genau den richtigen Influencer, um deine Zielgruppe mit deiner Brand zu erreichen. Unser Algorithmus identifiziert anhand mehrerer Variablen, den Influencer mit dem für dich größten Brand-Fit. Hierbei kannst du diverse Arten von Deals anbieten, von Barter-Deal bis hin zu einem bezahlten Placement. Dein größter Vorteil? Auf unserer Plattform findest du stets die aktuellen Social Media Kits aller Influencer und kannst somit on Demand alle Zielgruppendaten und entscheidungsrelevanten KPIs einsehen. Du bezahlst nur den Influencer und mehr nicht.
Investor & Business Development
Dec 2022
MukoCell GmbH is a Biotechnology company based in Dortmund, Bochum und Düsseldorf
Board Member & Investor
Nov 2022
ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries. From research through product commercialization, we provide the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics as well as gene and cell therapy platforms.
Our deep history of analytical leadership in protein-based therapeutics stems from the merger of Protagen Protein Services in Europe and BioAnalytix in the US. In 2021, GeneWerk’s unique capabilities in vector safety, integration site analysis, and bioinformatics were added to our portfolio, establishing ProtaGene. Our combined protein- and gene-based analytical platforms make it the leading analytic service provider across the biopharmaceutical and gene and cell therapy development spaces. The organization operates four sites in Europe and North America and works in advanced therapeutic platforms with leading biopharmaceutical and gene therapy companies worldwide.
Experience · 7 entries
All (7)
Investments (7)
Board (1)
2025
Board & Investor
Jan 2025
Your new teammate in the lab! Our lab platform takes over tedious and error-prone manual tasks in 3D cell culture, aiming to replace animal studies. A standardised repository of protocols lets you set up new experiments within minutes. Our AI-based quality control provides real-time transparency on the state of your cell culture, allowing you to worry less and make well-informed decisions.
2024
Investor
Jan 2024
Lindis Blood Care is a medical technology company aiming to set the new gold standard in oncological blood management by combining currently used filter technologies with its trifunctional antibody to reliably remove EpCAM-positive cancer cells from intraoperative blood with its medical device CATUVAB®.
CATUVAB® has the potential of making autologous blood transfusion possible during oncological surgeries, by ensuring that no tumor cells with metastasizing potential will be given back to the patient. Thereby making autologous blood transplant accessible to cancer patients while eliminating the negative side effects associated with allogenic blood transfusions.
2023
Seed Investor
Dec 2023
👉Our vision: Bringing the search experience known from the web into each company. amberSearch offers a multimedial enterprise search that makes the knowledge contained within pictures, videos, text or audio files available to every employee to work based on that knowledge rather than recreating knowledge.
👉The problem: Have you ever spend too much time looking for that all important piece of information within your company? A third of us spend between 5-25 minutes searching every time (!) we want to find the right information within our company.
👉Our solution: An intelligent and multimedia enterprise search engine to help employees to quickly and fully capture all relevant information and documents within their organisation.
👉Want to find out more? Check out our website or read our success stories:
🔎 Müller Maschinentechnik: https://ambersearch.medium.com/m%C3%BCller-maschinentechnik-zentralisiert-zugang-zu-know-how-f%C3%BCr-mitarbeiter-erfolgreich-ff7a108da4bb
🔎 RAG: https://ambersearch.medium.com/wie-expertenwissen-im-unternehmen-demokratisiert-werden-kann-am-beispiel-der-rag-2863cab99980
🔎 Blog amberSearch: https://ambersearch.medium.com/
Board Chair & Investor
Aug 2023
RESPILIQ™ - “the liquid breath”
Premature babies in the incubator, patients with acute lung failure in the intensive care unit or COPD patients at home: they all suffer from the same potentially fatal condition: hypercapnia = an increased level of CO2 in the blood.
In Germany alone there are around 400,000 people a year!
Hypercapnia is one of the major challenges in the therapy of acute lung failure and long-term weaning in ICU and in the outpatient treatment of chronic obstructive pulmonary disease (COPD), which has not yet been adequately solved.
Our goal is to revolutionize therapy and significantly improve survival and, above all, the quality of life of these large patient groups suffering from hypercapnia.
Instead of tackling the problem through the lungs, RESPILIQ™ uses the human gut as a respiratory organ. The human intestine forms a highly effective exchange membrane for carbon dioxid (CO2). In the gut, RESPILIQ™ can bind CO2 from the intestinal fluid and excrete it via naturalis. Administered orally or rectally, RESPILIQ™ initiates a life-saving reduction of pCO2 in the blood.
O11 biomedical GmbH is a spin-off from the Institute for Applied Medical Engineering, Dept. of Biohybrids & Medical Textiles (BioTex) at RWTH Aachen University | Aachen University Hospital. Our team consists of highly dedicated biologists, physicians and engineers.
The product development center is located on the Brightlands Chemelot Campus in close cooperation with the Aachen Maastricht Institute for Biobased Materials (AMIBM).
Investor Pre-Seed
Jan 2023
Was ist Leadnow?
Wir sind ein junges, dynamisches Start-up aus Stuttgart, dessen Ziel es ist, das Influencer-Marketing auf ein völlig neues Level zu heben. Mit unserer Plattform connecten wir Influencer mit den passenden Unternehmenskunden und ermöglichen so, den authentischsten Markenauftritt für beide Seiten zu gewährleisten.
Du bist Influencer?
Als Influencer profitierst du bei uns einerseits von den zahlreichen Kooperationsangeboten und andererseits von einer unkomplizierten Vertragsabwicklung, ohne die dir bekannten bürokratischen Hindernisse. Damit du dich vollkommen auf dein Business fokussieren kannst, übernehmen wir für dich die Rechnungsausstellung, sowie das nachträgliche Reporting. Zudem kannst du dir gefiltert nur die Kooperationen anzeigen lassen, die für dich persönlich finanziell attraktiv sind.
Du hast ein Unternehmen?
Als Unternehmen findest du bei uns genau den richtigen Influencer, um deine Zielgruppe mit deiner Brand zu erreichen. Unser Algorithmus identifiziert anhand mehrerer Variablen, den Influencer mit dem für dich größten Brand-Fit. Hierbei kannst du diverse Arten von Deals anbieten, von Barter-Deal bis hin zu einem bezahlten Placement. Dein größter Vorteil? Auf unserer Plattform findest du stets die aktuellen Social Media Kits aller Influencer und kannst somit on Demand alle Zielgruppendaten und entscheidungsrelevanten KPIs einsehen. Du bezahlst nur den Influencer und mehr nicht.
Show all 7 entries ↓
Investment activity
2022–2025 · 7 investments
Recent (last 2 years)Earlier
